News

7 August 2022

Positive GMP Inspection

Dear Customers,

During 6-9 August 2019, our API manufacturing site in Starogard Gdanski was inspected by GMP Inspectors from the Chief Pharmaceutical Inspectorate.

GMP Inspectors carry out the inspection to check whether we follow the GMP and GDP requirements in the scope of manufacture, import and distribution of active pharmaceutical ingredients.

Product Inspections verify product quality on site at different stages of the production process and prior to its dispatch. Inspecting production cycle by national inspectors, is an effective way of preventing quality problems and supply chain disruptions further down the line.

Inspectors thanked for our professionalism and commitment.

We are proud to announce the results are continuously positive.

Read more

Polpharma B2B Around the World 2018!
CPHI China is finally here and Polpharma B2B Team is looking forward to meet you at our booth E1D18!
CPhI MEA 2019